<DOC>
	<DOCNO>NCT02070692</DOCNO>
	<brief_summary>The purpose study study whether drug call tamoxifen reduce vaginal bleeding woman use Etonogestrel contraceptive implant .</brief_summary>
	<brief_title>Tamoxifen Treatment Unfavorable Bleeding Contraceptive Implant Users</brief_title>
	<detailed_description>Nearly 3 million unintended pregnancy United States year result inconsistent non-use contraception . Increasing use effective method contraception reduce unintended pregnancy social , medical economic consequence . The contraceptive etonogestrel implant ( ENG implant ) 20 time effective pregnancy prevention oral contraceptive pill , bleed side effect make unappealing many woman . Tamoxifen , selective estrogen receptor modulator ( SERM ) use commonly adjuvant treatment breast cancer , previously show dramatically reduce bleed user old levonorgestrel-based contraceptive implant ( Norplant tm ) . It study new progestin-based method ENG implant . If tamoxifen could stop bleed user ENG implant , would give patient physician valuable option management progestin-induced irregular bleeding . This research project test effectiveness tamoxifen take as-needed basis treat abnormal bleeding ENG implant user . If tamoxifen establish effective treatment frequent prolong bleeding , increase acceptability ENG implant , increase use reduce unintended pregnancy . This first project evaluate tamoxifen treatment unfavorable bleed user ENG contraceptive implant .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menstruation Disturbances</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Current user etonogestrel implant ( Nexplanon , Implanon ) least one month Experiencing bleed episode frequently every 24 day , single episode bleed lasting longer 14 day English Spanish speaking Planning continue implant use six month Access cell phone accept send text message Postpartum within six month Postabortion within six week Pregnant Breastfeeding Undiagnosed abnormal uterine bleed predate placement contraceptive implant Bleeding dyscrasia Anticoagulation use Active cervicitis Allergy tamoxifen History venous thromboembolism Current past breast uterine malignancy Use medication contraindicate tamoxifen ( coumadin , letrozole , bromocriptine , rifampicin , aminoglutethimide , phenobarbital )</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Contraceptive implant</keyword>
	<keyword>Irregular vaginal bleeding</keyword>
	<keyword>Etonogestrel implant</keyword>
</DOC>